JAK2/STAT3 Signaling Mediates IL-6-inhibited Neurogenesis of Neural Stem Cells Through DNA Demethylation/methylation

Xuejian Kong,Zhuo Gong,Le Zhang,Xiangdong Sun,Zhanhui Ou,Biao Xu,Jingyi Huang,Dahong Long,Xiaosong He,Xiaohong Lin,Qingqing Li,Liping Xu,Aiguo Xuan
DOI: https://doi.org/10.1016/j.bbi.2019.01.027
2019-01-01
Abstract:Neuroinflammation, considered as a pathological hallmark of Alzheimer's disease (AD), has been demonstrated to affect hippocampal neurogenesis and cognitive function. Interleukin-6 (IL-6) is a proinflammatory cytokine known to modulate neurogenesis. However, the mechanisms are still largely unknown. Here, we reported that IL-6 suppressed neurogenesis via a JAK2/STAT3 signaling in neural stem cells (NSCs). Importantly, we found that NeuroD1 (Neurogenic differentiation 1) gene expression, which drives NSCs neurodifferentiation, was regulated by TET3 and DNMT1 in a JAK2/STAT3-dependent manner. We further found that JAK2/STAT3 inhibition enhanced demethylation of NeuroD1 regulatory elements in IL-6-treated cells, which is related to the significant upregulation of TET3 expression as well as the decreased expression of DNMT1. Furthermore, Inhibiting JAK2/STAT3 significantly rescued the memory deficits and hippocampal neurogenesis dysfunction in APP/PS1 mice. Our data suggest that JAK2/STAT3 signaling plays a vital role in suppressing neurogenesis of NSCs exposed to IL-6 at the epigenetic level, by regulating DNA methylation/demethylation.
What problem does this paper attempt to address?